Log in to save to my catalogue

Cardiovascular effects of sphingosine‐1‐phosphate and other sphingomyelin metabolites

Cardiovascular effects of sphingosine‐1‐phosphate and other sphingomyelin metabolites

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1575924

Cardiovascular effects of sphingosine‐1‐phosphate and other sphingomyelin metabolites

About this item

Full title

Cardiovascular effects of sphingosine‐1‐phosphate and other sphingomyelin metabolites

Publisher

Oxford, UK: Blackwell Publishing Ltd

Journal title

British journal of pharmacology, 2004-11, Vol.143 (6), p.666-684

Language

English

Formats

Publication information

Publisher

Oxford, UK: Blackwell Publishing Ltd

More information

Scope and Contents

Contents

Upon various stimuli, cells metabolize sphingomyelin from the cellular plasma membrane to form sphingosylphosphorylcholine (SPC) or ceramide. The latter can be further metabolized to sphingosine and then sphingosine‐1‐phosphate (S1P). Apart from local formation, S1P and SPC are major constituents of blood plasma.
All four sphingomyelin metabolit...

Alternative Titles

Full title

Cardiovascular effects of sphingosine‐1‐phosphate and other sphingomyelin metabolites

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1575924

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1575924

Other Identifiers

ISSN

0007-1188

E-ISSN

1476-5381

DOI

10.1038/sj.bjp.0705934

How to access this item